A Randomised Controlled Trial of Iodide Supplementation in Preterm Infants Follow-up at 2 Years
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to determine whether iodide supplementation of neonates born
under 31 weeks gestation improves neurodevelopment measured at two years of age.
Phase:
Phase 4
Details
Lead Sponsor:
University of Oxford
Collaborators:
National Institute for Health Research, United Kingdom University of Dundee